• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Storz & Bickel Named "Equipment Provider of the Year" at Business of Cannabis Awards 2025

    7/8/25 7:30:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $CGC alert in real time by email

    Award recognizes innovation and technical excellence in vaporization technology

    Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, is pleased to share that Storz & Bickel has been awarded Equipment Provider of the Year at the 2025 Business of Cannabis Awards, held during the Cannabis Europa conference in London.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250708942770/en/

    Storz & Bickel Named

    Storz & Bickel Named "Equipment Provider of the Year" at Business of Cannabis Awards 2025

    The award recognizes companies delivering best-in-class equipment across the cannabis value chain - from cultivation and extraction to packaging and vaporization. Winners are selected by a panel of independent industry judges following a multi-step evaluation based on written submissions.

    Storz & Bickel's nomination, Pioneering Precision in Cannabis Vaporization, showcased the brand's nearly three-decade leadership in vaporization. Known for their engineering precision and product durability, highlights from the submission included:

    • The iconic VOLCANO tabletop vaporizer, launched in 2000 with patented convection technology.
    • The VENTY, released in 2024, offering rapid 20-second heat-up, adjustable airflow up to 20 L/min, and full temperature control.
    • Broad impact across both medical and recreational markets, with the VOLCANO MEDIC certified for medical use in several countries, as well as notable culinary applications by global chefs.

    "Storz & Bickel continues to raise the bar for what's possible in vaporization technology," said Luc Mongeau, Chief Executive Officer, Canopy Growth. "This award is a testament to their commitment to innovation, precision, and delivering a world-class vaporization experience to adult consumers and patients around the world."

    Storz & Bickel's vaporizers are available in over 120 countries and trusted by medical patients and wellness consumers. Their reputation is built on precision engineering, product reliability, and compliance with international quality standards like ISO 13485.

    "We're honored to be recognized with awards like these, which reflect the dedication of our entire team to pushing the boundaries of vaporization technology," said Jürgen Bickel, Co-Founder and Managing Director, Storz & Bickel. "From the VOLCANO to the VENTY, our focus has always been on engineering high-performance, reliable devices that meet the needs of patients and adult consumers around the world."

    The Business of Cannabis Award adds to a growing list of recent honours for Storz & Bickel. The VENTY was named "Vaporizer of the Year" at The EMJAYs1 and "Best Portable Vaporizer" by Vaping3602. The company also picked up American Accessory Brand of the Year from ADCANN3 and its Marketing and PR efforts earned first prize at the 2024 MarCom Awards for event execution4.

    About Canopy Growth

    Canopy Growth is a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives.

    Through an unwavering commitment to our consumers, Canopy Growth delivers innovative products with a focus on premium and mainstream cannabis brands including Tweed, 7ACRES, DOJA, Deep Space and Claybourne, as well as category-defining vaporization devices by Storz & Bickel. In addition, Canopy Growth serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.

    Canopy Growth has also established a comprehensive ecosystem to realize the opportunities presented by the U.S. THC market through an unconsolidated, non-controlling interest in Canopy USA. Canopy USA's portfolio includes ownership of Acreage Holdings, a vertically integrated multi-state cannabis operator with operations throughout the U.S. Northeast and Midwest, as well as ownership of Wana Brands, a leading North American edibles brand, and majority ownership of Jetty Extracts, a California-based producer of high-quality cannabis extracts and clean vape technology.

    At Canopy Growth, we're shaping a future where cannabis is embraced for its potential to enhance well-being and improve lives. With high-quality products, a commitment to responsible use, and a focus on enhancing the communities where we live and work, we're paving the way for a better understanding of all that cannabis can offer.

    For more information visit www.canopygrowth.com.

    About STORZ & BICKEL GmbH:

    STORZ & BICKEL GmbH is the global leading manufacturer of high-end and medically certified cannabis vaporizers. With their commitment to quality, innovation, and compliance, the company has consistently delivered exceptional products that meet the highest industry standards. Based in Tuttlingen, Germany, STORZ & BICKEL continuously drives the advancement of vaporization technology, providing a safe and efficient means of consuming cannabis for medical purposes.

    For more information, visit www.storz-bickel.com/ www.vapormed.com

    1 2024 EMJAYs Winner: Vaporizer Product of the Year

    2 Vaping 360: Best Portable Dry Herb Vaporizers 2025

    3 ADCANN 2025: United States Accessory Brand of the Year

    4 2024 MarCom Awards: Gold - Storz & Bickel's VENTY Vaporizer Launch

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250708942770/en/

    More Information

    Alex Thomas

    Director, Communications

    [email protected]

    Investor Contact

    Tyler Burns

    Director, Investor Relations

    [email protected]

    Get the next $CGC alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CGC

    DatePrice TargetRatingAnalyst
    4/4/2023Underperform → Mkt Perform
    Bernstein
    11/2/2022$1.50Underperform
    Bernstein
    10/26/2022Sell → Hold
    Canaccord Genuity
    6/8/2022Market Perform → Underperform
    BMO Capital Markets
    3/22/2022Equal Weight → Underweight
    Barclays
    3/1/2022$14.00 → $9.00Equal-Weight
    Barclays
    2/18/2022$9.60 → $11.00Neutral
    Cantor Fitzgerald
    12/22/2021Neutral → Underperform
    BofA Securities
    More analyst ratings

    $CGC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Stewart Thomas Carlton claimed ownership of 73,971 shares (SEC Form 3)

      3 - Canopy Growth Corp (0001737927) (Issuer)

      7/11/25 5:20:17 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Yanofsky Theresa sold $12,823 worth of shares (10,425 units at $1.23), decreasing direct ownership by 11% to 84,360 units (SEC Form 4)

      4 - Canopy Growth Corp (0001737927) (Issuer)

      7/2/25 4:16:20 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Kruh Willy sold $12,876 worth of shares (10,468 units at $1.23), decreasing direct ownership by 12% to 73,390 units (SEC Form 4)

      4 - Canopy Growth Corp (0001737927) (Issuer)

      7/2/25 4:16:02 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care

    $CGC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Canopy Growth upgraded by Bernstein

      Bernstein upgraded Canopy Growth from Underperform to Mkt Perform

      4/4/23 9:09:41 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Bernstein initiated coverage on Canopy Growth with a new price target

      Bernstein initiated coverage of Canopy Growth with a rating of Underperform and set a new price target of $1.50

      11/2/22 6:11:10 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth upgraded by Canaccord Genuity

      Canaccord Genuity upgraded Canopy Growth from Sell to Hold

      10/26/22 7:36:52 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care

    $CGC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Canopy Growth Launches Deep Space Infused Pre-Rolls

      Deep Space infused pre-rolls part of Canopy Growth's strategy to lead in high-growth formats Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has launched Deep Space Infused pre-rolls, a high-potency pre-roll joint innovation that brings the brand's signature boldness into one of the fastest-growing categories in cannabis.1 Deep Space Infused pre-rolls combine high-quality flower with liquid diamonds and THCA diamonds to deliver THC levels above 60%. Offered in a 3x0.5g format, the initial lineup includes two terpene-rich flavours: Milky Way Melon Infused

      7/10/25 7:30:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth Appoints Tom Stewart as Interim Chief Financial Officer

      Appointment reflects the continued execution of Canopy Growth's FY26 strategy, with a focus on financial discipline, fundamentals, and commercial execution Mr. Stewart brings over 20 years of operational finance and accounting leadership to the interim CFO role, with deep experience in operations, compliance, and performance management Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced the appointment of Tom Stewart as Interim Chief Financial Officer, effective immediately. This press release features multimedia. View the full release here:

      7/9/25 8:55:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Storz & Bickel Named "Equipment Provider of the Year" at Business of Cannabis Awards 2025

      Award recognizes innovation and technical excellence in vaporization technology Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, is pleased to share that Storz & Bickel has been awarded Equipment Provider of the Year at the 2025 Business of Cannabis Awards, held during the Cannabis Europa conference in London. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250708942770/en/Storz & Bickel Named "Equipment Provider of the Year" at Business of Cannabis Awards 2025 The award recognizes companies deli

      7/8/25 7:30:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care

    $CGC
    SEC Filings

    See more
    • Canopy Growth Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Canopy Growth Corp (0001737927) (Filer)

      7/9/25 9:03:16 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 424B7 filed by Canopy Growth Corporation

      424B7 - Canopy Growth Corp (0001737927) (Filer)

      6/6/25 4:16:27 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 424B5 filed by Canopy Growth Corporation

      424B5 - Canopy Growth Corp (0001737927) (Filer)

      6/6/25 4:15:33 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care

    $CGC
    Leadership Updates

    Live Leadership Updates

    See more
    • Canopy Growth Appoints Tom Stewart as Interim Chief Financial Officer

      Appointment reflects the continued execution of Canopy Growth's FY26 strategy, with a focus on financial discipline, fundamentals, and commercial execution Mr. Stewart brings over 20 years of operational finance and accounting leadership to the interim CFO role, with deep experience in operations, compliance, and performance management Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced the appointment of Tom Stewart as Interim Chief Financial Officer, effective immediately. This press release features multimedia. View the full release here:

      7/9/25 8:55:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy USA Announces Appointment of Mr. M. Brooks Jorgensen as President

      A cannabis and beverage alcohol industry executive with more than 25 years of experience, Mr. Jorgensen will lead the unified Canopy USA organization forward with a focus on driving profitable growth across the U.S. With the completed acquisitions of Acreage, Wana, and Jetty, Canopy USA now enters a new chapter of growth across key segments including flower, edibles, vapes, extracts, and through an established retail presence in high potential markets across the Midwest and Northeast BOULDER, Colo., January 6, 2025 /PRNewswire/ - Canopy USA, LLC ("Canopy USA"), a brand-driven organization strategically positioned across the fastest growing states and highest potential segments of the U.S. c

      1/6/25 7:30:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth Announces Results of Annual General Meeting

      SMITHS FALLS, ON, Sept. 25, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) is pleased to announce today the voting results from its annual general meeting of shareholders held on September 24, 2024 (the "Meeting"). All of the matters put forward before the Company's shareholders for consideration and approval, as set out in the Company's definitive proxy statement dated August 1, 2024 (the "Proxy Statement"), were approved by the requisite number of votes cast at the Meeting, as further detailed below. Each of the direc

      9/25/24 7:30:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care

    $CGC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Canopy Growth Corporation (Amendment)

      SC 13D/A - Canopy Growth Corp (0001737927) (Subject)

      4/19/24 5:00:49 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D/A filed by Canopy Growth Corporation (Amendment)

      SC 13D/A - Canopy Growth Corp (0001737927) (Subject)

      11/3/23 4:30:53 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D/A filed by Canopy Growth Corporation (Amendment)

      SC 13D/A - Canopy Growth Corp (0001737927) (Subject)

      7/20/23 4:35:52 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care

    $CGC
    Financials

    Live finance-specific insights

    See more
    • Canopy Growth Reports Fourth Quarter and Fiscal Year 2025 Financial Results

      Canada cannabis revenue increased 4% in Q4 FY2025 year-over-year, led by 13% growth in Canada medical cannabis Reduced total debt by $293 million or 49% during FY2025 Refined strategy, focus and organizational structure expected to accelerate growth in global medical cannabis and improve commercial execution in Canada adult-use cannabis Additional cost reduction initiatives identified and initiated in Q4 FY2025 are expected to deliver at least $20 million in annualized savings over the next 12-18 months Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced its financial results for the fourth quarter ended March 31, 2025 ("Q4 FY2025") a

      5/30/25 7:00:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth to Report Fourth Quarter and Fiscal Year 2025 Financial Results on May 30, 2025

      Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED, NASDAQ:CGC) will release its financial results for the fourth quarter and fiscal year 2025 ended March 31, 2025, before financial markets open on May 30, 2025. Following the release of its fourth quarter and fiscal year 2025 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and Judy Hong, CFO on May 30, 2025, at 10 AM Eastern Time (ET). Webcast Information A live audio webcast will be available at: https://onlinexperiences.com/Launch/QReg/ShowUUID=1235414F-AB39-4A0B-871E-B1885B487ACD Replay Information A replay will be accessible by webcast until 11:59 PM ET on August 28, 2025 at:

      5/16/25 7:30:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • The Week in Canadian Press Releases: 10 Stories You Need to See

      A roundup of the most newsworthy press releases from Cision Distribution this week TORONTO, Feb. 14, 2025 /CNW/ - With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that

      2/14/25 6:18:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care